Your browser doesn't support javascript.
loading
Enhanced TLR2 responses in multiple sclerosis.
Fujiwara, M; Anstadt, E J; Flynn, B; Morse, K; Ng, C; Paczkowski, P; Zhou, J; Mackay, S; Wasko, N; Nichols, F; Clark, R B.
  • Fujiwara M; Departments of Immunology and Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
  • Anstadt EJ; Departments of Immunology and Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
  • Flynn B; IsoPlexis, Branford, CT, USA.
  • Morse K; IsoPlexis, Branford, CT, USA.
  • Ng C; IsoPlexis, Branford, CT, USA.
  • Paczkowski P; IsoPlexis, Branford, CT, USA.
  • Zhou J; IsoPlexis, Branford, CT, USA.
  • Mackay S; IsoPlexis, Branford, CT, USA.
  • Wasko N; Departments of Immunology and Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
  • Nichols F; Division of Periodontology, University of Connecticut School of Medicine and School of Dental Health, Farmington, CT, USA.
  • Clark RB; Departments of Immunology and Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
Clin Exp Immunol ; 193(3): 313-326, 2018 09.
Article en En | MEDLINE | ID: mdl-30043528
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encefalomielitis Autoinmune Experimental / Receptor Toll-Like 2 / Microbiota / Inmunoterapia / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encefalomielitis Autoinmune Experimental / Receptor Toll-Like 2 / Microbiota / Inmunoterapia / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article